4//SEC Filing
Rolke James 4
Accession 0001193125-26-010648
CIK 0001810560other
Filed
Jan 11, 7:00 PM ET
Accepted
Jan 12, 5:21 PM ET
Size
5.3 KB
Accession
0001193125-26-010648
Insider Transaction Report
Form 4
Rolke James
DirectorChief Executive Officer
Transactions
- Award
Common Stock
[F1]2026-01-08$0.90/sh+532,829$479,546→ 933,489 total
Holdings
- 400,660
Common Stock
Footnotes (1)
- [F1]Restricted Stock Units under the 2021 Equity Incentive Plan. Vests quarterly over two years from the date of grant.
Signature
/s/ J.P. Galda, as attorney-in-fact for James Rolke|2026-01-12
Documents
Issuer
REVELATION BIOSCIENCES, INC.
CIK 0001810560
Entity typeother
Related Parties
1- filerCIK 0001693858
Filing Metadata
- Form type
- 4
- Filed
- Jan 11, 7:00 PM ET
- Accepted
- Jan 12, 5:21 PM ET
- Size
- 5.3 KB